Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

CV Screening, Care at UK Football Club Made Inroads Against HF

Caitlin E. Cox

March 07, 2025

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Daily News

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

Caitlin E. Cox

September 20, 2024

News Daily News

Emulsifiers in Food Up CVD Risk and Should Be Avoided, Study Urges

Yael L. Maxwell

September 21, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Opinion CV Team Dispatch

April 2020 News Roundup

L.A. McKeown

April 10, 2020

News Daily News

Troubling Rise in CVD and Other Noncommunicable Disease in Tropical Nations

Shelley Wood

July 27, 2018

News Daily News

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Shelley Wood

February 28, 2017

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Daily News

控制良好的华法林不会降低三联疗法出血风险

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Advertisement

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

CV Screening, Care at UK Football Club Made Inroads Against HF

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

Emulsifiers in Food Up CVD Risk and Should Be Avoided, Study Urges

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

April 2020 News Roundup

Troubling Rise in CVD and Other Noncommunicable Disease in Tropical Nations

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

肺栓塞发作后，二级抗凝效果未持续

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

控制良好的华法林不会降低三联疗法出血风险

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content